L1764

(±)-Lorazepam

• 同義詞: 7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one
• 經驗公式（希爾表示法）: C₁₅H₁₀Cl₂N₂O₂
• CAS號碼: 846-49-1
• 分子量：: 321.16
• EC號碼: 212-687-6
• MDL號碼: MFCD00063406
• 分類程式碼代碼: 12352200
• PubChem物質ID: 24896291
• NACRES: NA.77

屬性

• 品質等級: 200
• 藥物控制: USDEA Schedule IV; Home Office Schedule 4.1; psychotrope (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)
• 起源: Baxter
• SMILES 字串: OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O
• InChI: 1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)
• InChI 密鑰: DIWRORZWFLOCLC-UHFFFAOYSA-N
• 基因資訊: human ... GABRA1(2554) , GABRA2(2555) , GABRA3(2556) , GABRA4(2557) , GABRA5(2558) , GABRA6(2559) , GABRB1(2560) , GABRB2(2561) , GABRB3(2562) , GABRD(2563) , GABRE(2564) , GABRG1(2565) , GABRG2(2566) , GABRG3(2567) , GABRP(2568) , GABRQ(55879)

描述

生化／生理作用

Anxiolytic; ligand for the GABA_A receptor benzodiazepine modulatory site.

特點和優勢

This compound was developed by Baxter. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

安全資訊

• 象形圖: GHS08
• 訊號詞: Warning
• 危險聲明: H361d
• 防範說明: P201 - P202 - P280 - P308 + P313 - P405 - P501
• 危險分類: Repr. 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable
• 個人防護裝備: Eyeshields, Gloves, type P3 (EN 143) respirator cartridges